Neonatal Sepsis in the Age of Artificial Intelligence: Emerging Research, Diagnostic Challenges, and Future Directions in Neonatal Care

Neonatal sepsis continues to represent one of the most critical challenges in neonatal and pediatric care despite major advances in medicine, intensive care technologies, and antimicrobial therapy. The persistent burden of morbidity and mortality associated with neonatal sepsis especially in low- and middle-income countries raises important questions regarding our current diagnostic approaches, treatment strategies, and preventive interventions. Delayed diagnosis, nonspecific clinical presentation, antimicrobial resistance, and limited access to advanced laboratory support remain significant barriers to improved neonatal outcomes. As emerging research continues to explore novel biomarkers, molecular diagnostics, immune profiling, and precision medicine, there is increasing interest in how Artificial Intelligence (AI) and machine learning may transform neonatal care. AI-driven predictive models, electronic health record analytics, real-time monitoring systems, and early warning algorithms may offer opportunities for earlier recognition of sepsis, improved risk stratification, optimized antibiotic stewardship, and ultimately reduced neonatal mortality. However, important concerns also remain regarding data quality, ethical implications, implementation feasibility, and healthcare inequities, particularly in resource-limited settings.

Thus, the aim to stimulate an interdisciplinary scientific discussion on the future of neonatal sepsis research and management in the era of digital health and AI innovation. Can AI truly enhance clinical decision-making in neonatal intensive care units, or are we overestimating its current capabilities? Are current biomarkers sufficient for early and accurate diagnosis, or should future research focus more on genomics and precision medicine? How can we balance the urgent need for empirical antibiotic treatment with the growing threat of antimicrobial resistance? Additionally, what practical strategies can be adopted to ensure equitable implementation of AI technologies across different healthcare systems globally? I would be very interested to hear perspectives on the most pressing research gaps, emerging innovations, and future directions in neonatal sepsis care. particularly in the era of AI and Machine Learning.

Many thanks,

Isatou